Jan 10, 2013 | Recent Deals | Silicon Valley
Cooley LLP announced today that it represented BioMarin Pharmaceuticals Inc. in its acquisition of Zacharon Pharmaceuticals, a private biotechnology company based in San Diego. Under the terms of the agreement, BioMarin paid $10 million upfront for 100 percent of Zacharon’s share capital with the potential to make additional payments.
The Cooley team was led by mergers & acquisitions partner Jennifer Fonner DiNucci and included partners Marya Postner, Renee Deming and Natasha Leskovsek; senior counsels Lois Voelz and Buff Miller; and associates Dan Espinoza, Robin Bennett, Eric Chow, Laura McDaniels and Michael Baker.
BioMarin announced the transaction here.
Related Posts:
- Cooley Represents IDEV Technologies in Its Acquisition by Abbott Labs
- Cooley Advises Jazz Pharmaceuticals in Acquisition of ADX-N05
- Cooley Represents NextBio in Its Acquisition by Illumina
- Cooley Advises Viki on Its Acquisition by Rakuten
- Cooley Represents Quickoffice in its Sale to Google
